Home/Filings/4/0001209191-19-052988
4//SEC Filing

LEVIN JEREMY M 4

Accession 0001209191-19-052988

CIK 0001636651other

Filed

Oct 9, 8:00 PM ET

Accepted

Oct 10, 8:32 PM ET

Size

7.0 KB

Accession

0001209191-19-052988

Insider Transaction Report

Form 4
Period: 2019-10-08
LEVIN JEREMY M
DirectorCEO
Transactions
  • Purchase

    Common Stock

    2019-10-08$2.50/sh+60,000$150,0004,736,529 total
Holdings
  • Common Stock

    (indirect: See Footnote)
    465,116
  • Common Stock

    (indirect: See Footnote)
    35,461
Footnotes (3)
  • [F1]Shares were purchased in a Public Offering of the Issuer at a public offering price of $2.50.
  • [F2]The reportable securities are owned directly by Divo Holdings, LLC ("Divo"). The Reporting Person's spouse is the manager of Divo. The Reporting Person disclaims beneficial ownership of the shares held by Divo and this report shall not be deemed an admission of beneficial ownership of such shares for the purposes of Section 16 or for any other purpose.
  • [F3]The reportable securities are owned directly by DSL-EAL Holdings LLC (the "LLC"). The Reporting Person is the manager of the LLC. The Reporting Person may be deemed to share voting and investment powers for the shares held by the LLC. The Reporting Person disclaims beneficial ownership of the shares held by the LLC and this report shall not be deemed an admission of beneficial ownership of such shares for the purposes of Section 16 or for any other purpose, except to the extent of any pecuniary interest therein.

Issuer

Ovid Therapeutics Inc.

CIK 0001636651

Entity typeother

Related Parties

1
  • filerCIK 0001256153

Filing Metadata

Form type
4
Filed
Oct 9, 8:00 PM ET
Accepted
Oct 10, 8:32 PM ET
Size
7.0 KB